| Bioactivity | SMARCA2 degrader-17 is a SMARCA2 degrader. SMARCA2 degrader-17 shows synergistic anti-proliferation effects with Adagrasib (HY-130149) in cancer cells. SMARCA2 degrader-17 inhibits tumor growth[1]. |
| CAS | 2755761-78-3 |
| Formula | C47H58N10O6S |
| Molar Mass | 891.09 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Koichi Ito, et al. Improved treatment of cancers using combinations of smarca2 degraders and kras targeting therapies. Patent. WO2024076985A2 |
SMARCA2 degrader-17
CAS: 2755761-78-3 F: C47H58N10O6S W: 891.09
SMARCA2 degrader-17 is a SMARCA2 degrader.SMARCA2 degrader-17 shows synergistic anti-proliferation effects with Adagrasi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.